Donate For Public and Patients Store Search

F078 - Late-breaking Research: Clinical Studies/Pediatric

Saturday, March 2; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe ground-breaking scientific developments in dermatologic research.
  • Evaluate and apply information from recent investigations to clinical practice.


Researchers can submit abstracts describing their most recent unpublished results. After a competitive review, the top scoring studies will be invited to discuss their findings in a brief oral presentation during one of the themed sessions. This year, there will be three Forums (clinical/pediatric dermatology, surgery/procedural dermatology and basic science/dermatopathology) and a new Clinical Trials Symposium. Together, these sessions will highlight the latest ground-breaking observations in all aspects of dermatological research.


  • Barbieri, John S, MD: no financial relationships exist with commercial interests.
  • Davies, Olivia: no financial relationships exist with commercial interests.
  • Dellavalle, Robert Paul, MD, PhD: Altus Labs – C(ST); Cochrane Collaboration – O(OB); Department. of Veterans Affairs – E(S), I(Grants/Research Funding); Journal of Investigative Dermatology – Independent Contractor(OB); Journal of the American Academy of Dermatology – O(OB); ParaPRO LLC – C(Fees); Pfizer Inc. – I(Grants/Research Funding); University of Colorado – E(S); UpToDate, Inc – Independent Contractor(IP);
  • Eichenfield, Lawrence F., MD: Abbvie – I(Grants/Research Funding); Almirall – C(H); Anacor Pharmaceuticals, Inc. – C(H); Asana BioSciences – Data Safety Monitoring Board(H); Cutanea Life Sciences – C(H); Dermavant Sciences, Inc. – C(H); Dermira – C(H); Dr. Reddy – C(H); DS Laboratories – C(H); Elsevier Inc. – O(IP); Forte – A(H); Galderma Laboratories, L.P. – C(H), I(Fees); Glenmark Pharmaceuticals, Inc. – Data Safety Monitoring Board(H); LEO Pharma, US – C(H), I(Fees); Lilly ICOS LLC – C(H); MatriSys Bioscience – C(H); Medimetriks Pharmaceuticals, Inc. – C(H); Novan – C(H); Pfizer Inc. – C(H), I(Grants/Research Funding); Sanofi/Regeneron – C(H), I(Fees); TopMD – C(SO); Valeant Pharmaceuticals International – C(H); Valeant Pharmaceuticals North America LLC – I(Fees); Verrica Pharmaceuticals Inc – A(SO), C(H), I(Grants/Research Funding); Wiley-Blackwell – O(H);
  • Fernandez Faith, Esteban, MD: no financial relationships exist with commercial interests.
  • Igelman, Sean: no financial relationships exist with commercial interests.
  • Kahn, Benjamin: no financial relationships exist with commercial interests.
  • Kang, Sewon, MD: Almirall – A(H); Dermira – SH(ST); L'Oreal USA Inc. – O(NC); Sun Pharmaceutical Industries Ltd. – A(H); Unilever Home & Personal Care USA – A(H);
  • Li, David: no financial relationships exist with commercial interests.
  • MacLellan, Alexander, MD: no financial relationships exist with commercial interests.
  • Paller, Amy S., MD: AbbVie – I(NC); Amgen – C(H), I(NC); Amicus Therapeutics – C(H); Boehringer Ingelheim – C(H); BridgeBio Pharma, LLC – A(H), C(H); Castle Creek Pharmaceuticals – C(H); Celgene Corporation – I(NC); Chameleon Communications – C(H); Dermavant Sciences – C(H); Dermira – C(H); Eli Lilly and Company – C(H); Expanscience – Speaker/Faculty Education(H); Forte Biosciences – C(H); Galderma Laboratories, L.P. – C(H); Janssen Pharmaceuticals, Inc – I(NC); Leo Pharma Inc – I(Grants/Research Funding); Menlo Therapeutics – A(H), C(H); MorphoSys AG – C(H); Novartis Pharmaceuticals Corp. – C(H); Pfizer Inc. – C(H); Regeneron – C(H); Sanofi/Regeneron – A(H); Stiefel a GSK company – C(H); TARGET Pharma – C(H); Theravance Biopharma – C(H); Union Therapeutics – C(H); Valeant Pharmaceuticals North America LLC – C(H); Verrica Pharmaceuticals Inc – C(H);
  • Patel, Shaunak: no financial relationships exist with commercial interests.
  • Singer, Sean: no financial relationships exist with commercial interests.
  • Tsao, Hensin, MD, PhD: Asana Biosciences, LLC – I(Grants/Research Funding); Epiphany Dermatology – A(H); Massachusetts General Hospital – E(S); Relay Therapeutics – I(Grants/Research Funding); UpToDate, Inc. – O(H); Worldcare Clinical, LLC – C(H);
  • Wan, Joy, MD, MSCE: Pfizer Inc. – I(Grants/Research Funding);
  • Zakaria, Adam: no financial relationships exist with commercial interests.
Saturday, March 2
3:30 PM
Dr. MacLellan / A Melanoma Diagnostic Accuracy Study, Part I
3:40 PM
Patel / Disparities in Melanoma Skin Cancer Outcomes: Survival in Patients of Hispanic Origin
3:50 PM
Zakaria / Impact of Teledermatology on the Accessibility and Efficiency of Dermatology Care in an Urban Safety-Net Hospital
4:00 PM
Singer / Pregnancy-Related Adverse Events on Isotretinoin from 1997-2017
4:10 PM
Kahn / Underrepresentation of dermatologic disease in the risk-adjustment model used by the Centers for Medicare and Medicare Services
4:20 PM
Davies / Genotype-phenotype Correlation of Cutaneous Vascular Stain; When a difference makes a difference
4:30 PM
Dr. Fernandez Faith / Infantile Hemangioma Ulceration in the Era of Beta Blockers
4:40 PM
Igelman / Off-label Use of Dupilumab for Pediatric Patients with Atopic Dermatitis: A Multicenter Retrospective Review
4:50 PM
Dr. Wan / Mental Health Impairment Among Children with Eczema: A cross-sectional analysis of the 2013-2017 National Health Interview Survey
5:00 PM
Li / Trends in Spending for Combination Acne Products: Rising Costs and Potential Savings
5:10 PM
Dr. Eichenfield / CAMP-1 (Cantharidin Application in Molluscum Patients) and CAMP-2: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Studies Investigating VP-102, a Drug-device Combination Containing a N
5:20 PM
Dr. Barbieri / Use of Antibiotics in Dermatology Surgery from 2008-2016.
Event Details
  • Date
    Saturday, March 2
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 154A
  • CME Credits
  • Type
  • Adam Zakaria
  • Alexander MacLellan, MD
  • Amy S. Paller, MD, FAAD
  • Benjamin Kahn
  • David Li
  • Esteban Fernandez Faith, MD, FAAD
  • John S Barbieri, MD
  • Joy Wan, MD, MSCE, FAAD
  • Lawrence F. Eichenfield, MD, FAAD
  • Olivia Davies
  • Robert Paul Dellavalle, MD, PhD, FAAD
  • Sean Igelman
  • Sean Singer
  • Sewon Kang, MD, FAAD
  • Shaunak Patel